Supernus Pharma (SUPN) Misses Q2 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Supernus Pharma (SUPN) Misses Q2 EPS

Supernus Announces Second Quarter 2023 Financial Results

August 8, 2023 4:17 PM EDT

Qelbree® net product sales growth of 179% and 193% in the first three months and first six months of 2023, respectively, compared to the same periods in 2022 $31.0 million and $56.8 million of net product sales in the first three months and first six months of 2023, respectively GOCOVRI® net product sales growth of 17% and 16% in the first three months and first six months of 2023, respectively, compared to the same periods in 2022 $28.8 million and $54.8 million of net product sales in the fist three months and first six months of 2023, respectively Total revenues of $289.3 million in the first... More